[go: up one dir, main page]

MA38599A1 - Novel pyrazolopyrrolidine derivatives and their use in the treatment of diseases - Google Patents

Novel pyrazolopyrrolidine derivatives and their use in the treatment of diseases

Info

Publication number
MA38599A1
MA38599A1 MA38599A MA38599A MA38599A1 MA 38599 A1 MA38599 A1 MA 38599A1 MA 38599 A MA38599 A MA 38599A MA 38599 A MA38599 A MA 38599A MA 38599 A1 MA38599 A1 MA 38599A1
Authority
MA
Morocco
Prior art keywords
diseases
novel
treatment
pyrazolopyrrolidine
derivatives
Prior art date
Application number
MA38599A
Other languages
French (fr)
Other versions
MA38599B1 (en
Inventor
Heinrich Rueeger
Jutta Blank
Vincent Bordas
Simona Cotesta
Vito Guagnano
Andrea Vaupel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/IB2014/061717 external-priority patent/WO2014191896A1/en
Publication of MA38599A1 publication Critical patent/MA38599A1/en
Publication of MA38599B1 publication Critical patent/MA38599B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La présente invention porte sur un composé de formule (i), ou un sel pharmaceutiquement acceptable de ce dernier; sur un procédé de préparation des composés de l'invention et sur leurs utilisations thérapeutiques. La présente invention concerne également une combinaison d'agents actifs du point de vue pharmacologique ainsi qu'une composition pharmaceutique.The present invention relates to a compound of formula (i), or a pharmaceutically acceptable salt thereof; on a process for preparing the compounds of the invention and on their therapeutic uses. The present invention also relates to a combination of pharmacologically active agents as well as a pharmaceutical composition.

MA38599A 2013-05-27 2014-05-26 Novel pyrazolopyrrolidine derivatives and their use in the treatment of diseases MA38599B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13169364 2013-05-27
PCT/IB2014/061717 WO2014191896A1 (en) 2013-05-27 2014-05-26 Pyrazolopyrrolidine derivatives and their use in the treatment of disease

Publications (2)

Publication Number Publication Date
MA38599A1 true MA38599A1 (en) 2018-01-31
MA38599B1 MA38599B1 (en) 2018-09-28

Family

ID=48470839

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38599A MA38599B1 (en) 2013-05-27 2014-05-26 Novel pyrazolopyrrolidine derivatives and their use in the treatment of diseases

Country Status (2)

Country Link
AR (1) AR096435A1 (en)
MA (1) MA38599B1 (en)

Also Published As

Publication number Publication date
AR096435A1 (en) 2015-12-30
MA38599B1 (en) 2018-09-28

Similar Documents

Publication Publication Date Title
MA34837B1 (en) INDOLIC COMPOUNDS OR ANALOGS THEREFOR USEFUL IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)
MA42678B1 (en) NEW SUBSTITUTED NUCLEOSIDE ANALOGS WITH BICYCLIC AROMATIC CYCLE 6-6 FOR USE AS PRMT5 INHIBITORS
MA37405A1 (en) Heterocyclyl compounds
MA34083B1 (en) PHARMACEUTICAL COMPOSITIONS OF SPIRO-OXINDOLE COMPOUND FOR TOPICAL ADMINISTRATION AND USE THEREOF AS THERAPEUTIC AGENTS
MA42230A (en) BICYCLIC DERIVATIVES, THEIR PREPARATION PROCESS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA37834A1 (en) 1,4-Disubstituted pyridazine analogs and methods of treating disorders related to Mn deficiency
MA43979B1 (en) 1h-indazole-3-carboxamide derivatives and similar compounds as d-factor inhibitors for the treatment of diseases characterized by aberrant activity of the complementary system, such as p.E. Immunological disorders
MA35576B1 (en) New compounds
EA201592256A1 (en) DERIVATIVES OF IMIDAZOPIRROLIDINONE AND THEIR APPLICATION IN THE TREATMENT OF DISEASES
MA37866B1 (en) Aza-indazole or diaza-indazole derivatives for the treatment of pain
MA37477A1 (en) Modulators of complement pathways and their uses
EA201592250A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of diseases
MA35032B1 (en) GLYCOSIDE DERIVATIVES AND THEIR USES IN THE TREATMENT OF DIABETES
MA37888A1 (en) Coated pharmaceutical composition containing regorafenib
MA47356B1 (en) Isochromene derivatives useful as inhibitors of phosphoinositide 3-kinases
EP3649119A1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
MA38330B1 (en) Butanoic phosphonic acid derivatives of bisphenol substituted as nep inhibitors (neutral endopeptidase)
MA38315A1 (en) Heterocycle-substituted tetracyclic compounds and methods for their use in the treatment of viral diseases
MA37990B1 (en) benzamides
MA39165A1 (en) Benzimidazole-proline derivatives for their use in the treatment of crepuscular state syndrome
MA39983A (en) CARBOXAMIDE DERIVATIVES
EA201400067A1 (en) NEW THERAPEUTIC COMPOSITION CONTAINING APOMORPHIN AS AN ACTIVE INGREDIENT
MA37763B1 (en) Difluoro-hexahydro-cyclopentaoxazinyl and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors
MA38679B1 (en) Cxcr7 receiver modulators
MA38410B1 (en) Azetidinyloxyphenylpyrrolidine compounds